BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND BTG1, P62324, 694, ENSG00000133639
54 results:

  • 1. Is 3T MR nerve-bone fusion imaging a viable alternative to MRI-CBCT to identify the relationship between the inferior alveolar nerve and mandibular third molar.
    Huang H; Yan Y; Jiang D; Zhao X; Cao D; She D
    Clin Oral Investig; 2024 Apr; 28(5):256. PubMed ID: 38630324
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A grayscale compression method to segment bone structures for 2D-3D registration of setup images in non-coplanar radiotherapy.
    Song Z; Li T; Zuo L; Song Y; Wei R; Dai J
    Biomed Phys Eng Express; 2024 Mar; 10(3):. PubMed ID: 38442730
    [No Abstract]    [Full Text] [Related]  

  • 3. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
    Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
    Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid-stimulating hormone suppression therapy: a new fracture risk assessment algorithm.
    Jia H; Qu W; Cai X; Li M; Qian Y; Jiang Z; Zhang Z
    Front Endocrinol (Lausanne); 2023; 14():1286947. PubMed ID: 38075039
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Montoro J; Boumendil A; Finel H; Bramanti S; Castagna L; Blaise D; Dominietto A; Kulagin A; Yakoub-Agha I; Tbakhi A; Solano C; Giebel S; Gulbas Z; López Corral L; Pérez-Simón JA; Díez Martín JL; Sanz J; Farina L; Koc Y; Socié G; Arat M; Jurado M; Bermudez A; Labussière-Wallet H; Villalba M; Ciceri F; Martinez C; Nagler A; Sureda A; Glass B
    Transplant Cell Ther; 2024 Feb; 30(2):210.e1-210.e14. PubMed ID: 38043802
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of pre-operative and post-operative radiotherapy in patients with localized myxoid liposarcoma.
    Masunaga T; Tsukamoto S; Honoki K; Fujii H; Kido A; Akahane M; Tanaka Y; Mavrogenis AF; Errani C; Kawai A
    Jpn J Clin Oncol; 2023 Dec; 53(12):1153-1161. PubMed ID: 37814462
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey.
    Passweg JR; Baldomero H; Ciceri F; Corbacioglu S; de la Cámara R; Dolstra H; Glass B; Greco R; McLornan DP; Neven B; de Latour RP; Perić Z; Ruggeri A; Snowden JA; Sureda A
    Bone Marrow Transplant; 2023 Jun; 58(6):647-658. PubMed ID: 36879108
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Predictors for self-discontinuation of anti-osteoporosis medication: A hospital-based real-world study.
    Deng YL; Hsu CS; Hsu CY; Chen CH; Ou SF; Liu CF; Yang SH; Shih CH; Chen YM; Lee HT
    PLoS One; 2022; 17(9):e0275020. PubMed ID: 36129951
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.
    Linabery AM; Roesler MA; Richardson M; Warlick ED; Nguyen PL; Cioc AM; Poynter JN
    Cancer Epidemiol; 2022 Feb; 76():102090. PubMed ID: 34995873
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
    Arabi YM; Gordon AC; Derde LPG; Nichol AD; Murthy S; Beidh FA; Annane D; Swaidan LA; Beane A; Beasley R; Berry LR; Bhimani Z; Bonten MJM; Bradbury CA; Brunkhorst FM; Buxton M; Buzgau A; Cheng A; De Jong M; Detry MA; Duffy EJ; Estcourt LJ; Fitzgerald M; Fowler R; Girard TD; Goligher EC; Goossens H; Haniffa R; Higgins AM; Hills TE; Horvat CM; Huang DT; King AJ; Lamontagne F; Lawler PR; Lewis R; Linstrum K; Litton E; Lorenzi E; Malakouti S; McAuley DF; McGlothlin A; Mcguinness S; McVerry BJ; Montgomery SK; Morpeth SC; Mouncey PR; Orr K; Parke R; Parker JC; Patanwala AE; Rowan KM; Santos MS; Saunders CT; Seymour CW; Shankar-Hari M; Tong SYC; Turgeon AF; Turner AM; Van de Veerdonk FL; Zarychanski R; Green C; Berry S; Marshall JC; McArthur C; Angus DC; Webb SA;
    Intensive Care Med; 2021 Aug; 47(8):867-886. PubMed ID: 34251506
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Expression and Clinical Significance of BCL2 Interacting Protein 3 Like in Multiple Myeloma.
    Li R; Chen G; Dang Y; He R; Liu A; Ma J; Ling Z
    Technol Cancer Res Treat; 2021; 20():15330338211024551. PubMed ID: 34189969
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
    Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer.
    Wu XT; Zhou JW; Pan LC; Ge T
    J Int Med Res; 2020 May; 48(5):300060520925644. PubMed ID: 32425092
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Disease expression in juvenile polyposis syndrome: a retrospective survey on a cohort of 221 European patients and comparison with a literature-derived cohort of 473 SMAD4/BMPR1A pathogenic variant carriers.
    Blatter R; Tschupp B; Aretz S; Bernstein I; Colas C; Evans DG; Genuardi M; Hes FJ; Hüneburg R; Järvinen H; Lalloo F; Moeslein G; Renkonen-Sinisalo L; Resta N; Spier I; Varvara D; Vasen H; Latchford AR; Heinimann K
    Genet Med; 2020 Sep; 22(9):1524-1532. PubMed ID: 32398773
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The outcome of patients with surgically treated meningioma in England: 1999-2013. A cancer registry data analysis.
    Brodbelt AR; Barclay ME; Greenberg D; Williams M; Jenkinson MD; Karabatsou K
    Br J Neurosurg; 2019 Dec; 33(6):641-647. PubMed ID: 31526136
    [No Abstract]    [Full Text] [Related]  

  • 17. Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
    Restrepo DJ; Huayllani MT; Boczar D; Sisti A; Spaulding AC; Carter RE; Moran SL; Parker AS; Perdikis G; Forte AJ
    Anticancer Res; 2019 Sep; 39(9):5027-5031. PubMed ID: 31519610
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
    Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A ten-year retrospective study investigating the rate of venous thromboembolism in patients who require immobilization in a total contact lower limb cast.
    Tonge XN; Widnall JC; Jackson G; Platt S
    Bone Joint J; 2019 Jun; 101-B(6):691-694. PubMed ID: 31154840
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy 
in Advanced NSCLC Patients with EGFR Mutations].
    Chen M; Xu Y; Zhao J; Zhong W; Wang M
    Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):99-104. PubMed ID: 30827326
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.